Inactivating mutations of BRCA1 and BRCA2 frequently occur in breast cancer as well [30], [36], [42], while unique mutations in GATA3, PIK3CA, and MAP3K1 are enriched in the luminal A subtype of breast cancer [25], [45]. This evidence concerns the gene BRCA2 and breast cancer.